SCHEMBL26219079

SCHEMBL26219079

Fc1cccc(-c2ccc(-c3ccc(-c4ccc5ccccc5c4)cc3)c3ccccc23)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 3/20 0.47
ESR2 Q92731 3/20 0.47
HSD17B1 P14061 1/20 0.46
HSD17B2 P37059 1/20 0.46
CYP1A2 P05177 3/20 0.46
CYP2A6 P11509 1/20 0.46
ESR1 P03372 2/20 0.44
GSTP1 P09211 1/20 0.44
NT5E P21589 1/20 0.43
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA9 Q16790 1/20 0.42
CYP1A1 P04798 2/20 0.42
CYP1B1 Q16678 2/20 0.42
PRKDC P78527 1/20 0.42
PDK2 Q15119 1/20 0.41
CYP17A1 P05093 2/20 0.40
CYP11B1 P15538 2/20 0.40
CYP11B2 P19099 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26750925 0.95 CYP1A2 (0.50) TAAR1ESR2HSD17B1HSD17B2CYP1A2
SCHEMBL26750951 0.87 CYP1A2 (0.48) ESR2HSD17B1HSD17B2CYP1A2CYP2A6
SCHEMBL26750939 0.86 CYP1A2 (0.52) ESR2HSD17B1HSD17B2CYP1A2CYP2A6
SCHEMBL3368772 0.86 CYP1A2 (0.60) TAAR1ESR2HSD17B1HSD17B2CYP1A2
SCHEMBL29892464 0.84 CYP1A2 (0.54) TAAR1ESR2HSD17B1HSD17B2CYP1A2
SCHEMBL26750831 0.84 ESR2 (0.47) TAAR1ESR2HSD17B1HSD17B2CYP1A2
SCHEMBL26750946 0.82 ESR1 (0.46) ESR2HSD17B1HSD17B2CYP1A2CYP2A6
SCHEMBL26750815 0.81 CYP1A2 (0.50) TAAR1ESR2HSD17B1HSD17B2CYP1A2
SCHEMBL26750974 0.81 CYP1A2 (0.43) ESR2HSD17B1HSD17B2CYP1A2CYP2A6
SCHEMBL24036628 0.81 ESR1 (0.57) ESR2HSD17B1HSD17B2ESR1GSTP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230365857-A1 ORGANIC MIXTURES AND APPLICATIONS THEREOF IN ORGANIC ELECTRONIC DEVICES Zhejiang Brilliant Optoelectronic Technology Co.,Ltd. (CN) 2023-11-16 US disclosed
US-20230365857-A1 ORGANIC MIXTURES AND APPLICATIONS THEREOF IN ORGANIC ELECTRONIC DEVICES Zhejiang Brilliant Optoelectronic Technology Co.,Ltd. (CN) 2023-11-16 US disclosed
US-20230363257-A1 ORGANIC MIXTURES AND APPLICATIONS THEREOF IN ORGANIC ELECTRONIC DEVICES Zhejiang Brilliant Optoelectronic Technology Co.,Ltd. (CN) 2023-11-09 US disclosed
US-20230363257-A1 ORGANIC MIXTURES AND APPLICATIONS THEREOF IN ORGANIC ELECTRONIC DEVICES Zhejiang Brilliant Optoelectronic Technology Co.,Ltd. (CN) 2023-11-09 US disclosed
EP-4234524-A2 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF Duk San Neolux Co., Ltd. (KR) 2023-08-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230365857-A1 ORGANIC MIXTURES AND APPLICATIONS THEREOF IN ORGANIC ELECTRONIC DEVICES H1-0, OR10J3, H1-2 TAAR1 863/4885ESR2 100/4885HSD17B1 840/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.